De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.

Transplantation proceedings

Volumn 44, Issue 8, 2012, Pages 2388-2390

  Caires, R A ^a   Marques, I D ^b   Repizo, L P ^b   Sato, V A ^b   Carmo, L P ^b   Machado, D J ^b   de Paula, F J ^b   Nahas, W C ^b   David Neto, E ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD COMPONENT THERAPY; DRUG SUBSTITUTION; EARLY DIAGNOSIS; FEMALE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PLASMAPHERESIS; PREDICTIVE VALUE; RETROSPECTIVE STUDY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TIME; TREATMENT OUTCOME;

ADULT; BLOOD COMPONENT TRANSFUSION; DRUG SUBSTITUTION; EARLY DIAGNOSIS; FEMALE; GRAFT SURVIVAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMAPHERESIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THROMBOTIC MICROANGIOPATHIES; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84874800434     PISSN: None     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.039     Document Type: Article

References (0)